Volume 6, Issue 4 (11-2019)                   J. Res. Orthop. Sci. 2019, 6(4): 25-30 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Valiollahi B, Salehpour M, Bashari H, Majdi S, Mohammadpour M. A Typical Metatarsal Fracture in a Patient on Long-Term Bisphosphonate Therapy. J. Res. Orthop. Sci. 2019; 6 (4) :25-30
URL: http://jros.iums.ac.ir/article-1-2043-en.html
1- Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
Abstract:   (1163 Views)
Bisphosphonates, more particularly alendronate, are a popular category of drugs in the treatment of postmenopausal and corticosteroid-induced osteoporosis. The present study contends that the long-term consumption of bisphosphonates causes not only subtrochanteric and femoral shaft fractures but also pathological fractures at other musculoskeletal sites. This report presents a rare case of alendronate-induced pathological metatarsal fracture in a 59-year-old female with a history of cuboid fracture following a twisting with abnormal Bone Mineral Density (BMD) (T score: −3.5; lumbar spine and −2.6; proximal femur).
Full-Text [PDF 1862 kb]   (779 Downloads) |   |   Full-Text (HTML)  (1370 Views)  
Type of Study: Case Report | Subject: Knee surgery
Received: 2019/05/3 | Accepted: 2019/12/25 | Published: 2019/12/25

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Research in Orthopedic Science

Designed & Developed by : Yektaweb